{"text": "HIV-1 infectious molecular clones", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The plasmid encoding the full-length infectious molecular clone of HIV-1Lai was obtained from the NIH AIDS Reagent and Reference Program .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The HIV-1Lai / Bal-Env infectious molecular clone was constructed by replacing the envelope ( env ) <extra_id_0> gp160 <extra_id_2> Protein <extra_id_1> amino acids 103-717 of the HIV-1Lai ( B subtype that utilizes <extra_id_0> CXCR4 <extra_id_2> Protein <extra_id_1> ) molecular clone with the corresponding region of HIV-1Bal ( B subtype that utilizes <extra_id_0> CCR5 <extra_id_2> Protein <extra_id_1> ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The HIV-1Lai / Bal-Env chimeric virus uses CCR5 as a secondary receptor .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The infectious molecular clone of HIV-198IN22 was constructed using DNA extracted from PBMC that were infected with a primary isolate of HIV-198IN22 .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "HIV-1Lai / Bal-Env and HIV-198IN22 mutant viruses were constructed by introducing point mutations using standard PCR-based mutagenesis methods .", "event": "<extra_id_0> <extra_id_1>"}
